萊美藥業(300006.SZ):股東邱宇及其一致行動人持股比例被動稀釋超5%及所持15.72萬股遭被動減持
格隆匯 3 月 18日丨萊美藥業(300006.SZ)公佈,根據中國證券監督管理委員會出具的《關於同意重慶萊美藥業股份有限公司向特定對象發行股票註冊的批覆》(證監許可[2021]437號),公司向廣西梧州中恆集團股份有限公司(“中恆集團”)、南寧中恆同德醫藥產業投資基金合夥企業(有限合夥)和廣西廣投國宏健康產業基金合夥企業(有限合夥)三名特定對象合計發行約2.44億股人民幣普通股(A股)股票,上述新增股份已在中國證券登記結算有限公司深圳分公司辦理完成股份登記手續,並將在深圳證券交易所上市交易。
此次發行完成後,公司總股本由約8.12億股增加至約10.56億股,股東邱宇及其一致行動人西藏萊美醫藥投資有限公司(“西藏萊美”)持股比例被動稀釋超過5%。此外,公司於近日收到股東邱宇吿知函,邱宇直接所持公司部分股份被司法強制執行,導致其被動減持15.72萬股,佔被動減持時公司總股本的0.019%,佔此次發行完成後公司總股本的0.015%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.